185 related articles for article (PubMed ID: 16280968)
21. Infliximab rescue therapy in ulcerative colitis, and the effect on subsequent colectomy rates.
Halpin SJ; Hamlin PJ; Ford AC
Aliment Pharmacol Ther; 2010 Nov; 32(10):1294-5. PubMed ID: 20955450
[No Abstract] [Full Text] [Related]
22. Infliximab avoiding colectomy and maintaining remission in pediatric immunosuppressive-naïve ulcerative colitis achieving remarkable mucosal healing.
Sciaudone G; Pellino G; Guadagni I; Selvaggi F
Panminerva Med; 2010 Mar; 52(1):91-2. PubMed ID: 20228729
[No Abstract] [Full Text] [Related]
23. Tumour necrosis factor alpha downregulation and therapeutic response to infliximab in a case of segmental colitis associated with diverticula.
Hassan C; Zullo A; Ierardi E; Burattini O; De Francesco V; Morini S
Gut; 2006 Apr; 55(4):589-90. PubMed ID: 16531548
[No Abstract] [Full Text] [Related]
24. What is the importance of infliximab and cyclosporine in the treatment of corticosteroid-refractory severe ulcerative colitis?
Bengi G; Akpinar H
Turk J Gastroenterol; 2012; 23 Suppl 2():7-12. PubMed ID: 23576083
[No Abstract] [Full Text] [Related]
25. A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis.
Lees CW; Heys D; Ho GT; Noble CL; Shand AG; Mowat C; Boulton-Jones R; Williams A; Church N; Satsangi J; Arnott ID;
Aliment Pharmacol Ther; 2007 Aug; 26(3):411-9. PubMed ID: 17635376
[TBL] [Abstract][Full Text] [Related]
26. Response to infliximab in atypical pyoderma gangrenosum associated with ulcerative colitis.
Fernández A; Velasco A; Prieto V; Canueto J; Alvarez A; Rodríguez A
Am J Gastroenterol; 2008 Nov; 103(11):2951-2. PubMed ID: 19032482
[No Abstract] [Full Text] [Related]
27. Infliximab: new indication. Ulcerative colitis: caution is needed due to long-term risks.
Prescrire Int; 2007 Oct; 16(91):194. PubMed ID: 17926832
[TBL] [Abstract][Full Text] [Related]
28. Meta-analysis: effect of preoperative infliximab use on early postoperative complications in patients with ulcerative colitis undergoing abdominal surgery.
Yang Z; Wu Q; Wang F; Wu K; Fan D
Aliment Pharmacol Ther; 2012 Nov; 36(10):922-8. PubMed ID: 23002804
[TBL] [Abstract][Full Text] [Related]
29. Colectomy rate in acute severe ulcerative colitis in the infliximab era.
Aratari A; Papi C; Clemente V; Moretti A; Luchetti R; Koch M; Capurso L; Caprilli R
Dig Liver Dis; 2008 Oct; 40(10):821-6. PubMed ID: 18472316
[TBL] [Abstract][Full Text] [Related]
30. Infliximab in ulcerative colitis.
Aberra FN; Lichtenstein GR
Gastroenterol Clin North Am; 2006 Dec; 35(4):821-36. PubMed ID: 17129815
[TBL] [Abstract][Full Text] [Related]
31. Pustular psoriasis induced by infliximab.
Thurber M; Feasel A; Stroehlein J; Hymes SR
J Drugs Dermatol; 2004; 3(4):439-40. PubMed ID: 15303790
[TBL] [Abstract][Full Text] [Related]
32. [Use of infliximab in ulcerative colitis].
Tilg H; Feichtenschlager T; Knoflach P; Petritsch W; Schöfl R; Vogelsang H; Reinisch W
Z Gastroenterol; 2007 Aug; 45(8):907-11. PubMed ID: 17701864
[TBL] [Abstract][Full Text] [Related]
33. Severe rosacea in a patient on infliximab for ulcerative colitis: pathophysiological considerations.
Kosmidou M; Gaitanis G; Nomikos K; Zioga A; Katsanos K; Bassukas ID; Tsianos E
Acta Derm Venereol; 2009; 89(5):522-3. PubMed ID: 19734983
[No Abstract] [Full Text] [Related]
34. Infliximab-associated alveolitis after treatment for severe left-sided ulcerative colitis.
Veerappan SG; O'Morain CA
Eur J Gastroenterol Hepatol; 2009 Jul; 21(7):830-2. PubMed ID: 19398919
[TBL] [Abstract][Full Text] [Related]
35. Predicting the response to infliximab from trough serum levels.
Rutgeerts P; Vermeire S; Van Assche G
Gut; 2010 Jan; 59(1):7-8. PubMed ID: 20007955
[No Abstract] [Full Text] [Related]
36. The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients.
Feagan BG; Reinisch W; Rutgeerts P; Sandborn WJ; Yan S; Eisenberg D; Bala M; Johanns J; Olson A; Hanauer SB
Am J Gastroenterol; 2007 Apr; 102(4):794-802. PubMed ID: 17324131
[TBL] [Abstract][Full Text] [Related]
37. Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up.
Kohn A; Daperno M; Armuzzi A; Cappello M; Biancone L; Orlando A; Viscido A; Annese V; Riegler G; Meucci G; Marrollo M; Sostegni R; Gasbarrini A; Peralta S; Prantera C
Aliment Pharmacol Ther; 2007 Sep; 26(5):747-56. PubMed ID: 17697208
[TBL] [Abstract][Full Text] [Related]
38. Anti-tumor necrosis factor therapy for ulcerative colitis.
Kountouras J; Zavos C; Chatzopoulos D
Gastroenterology; 2005 Sep; 129(3):1138-9. PubMed ID: 16143158
[No Abstract] [Full Text] [Related]
39. Medical treatment and management of severe ulcerative colitis.
Rizzello F; Campieri M; Tambasco R; Straforini G; Brugnera R; Poggioli G; Gionchetti P
Dig Liver Dis; 2008 Jul; 40 Suppl 2():S280-4. PubMed ID: 18599001
[TBL] [Abstract][Full Text] [Related]
40. Current management of severe ulcerative colitis.
Caprilli R; Viscido A; Latella G
Nat Clin Pract Gastroenterol Hepatol; 2007 Feb; 4(2):92-101. PubMed ID: 17268544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
